Condition
High-risk Non-Muscle Invasive Bladder Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 5 High-risk Non-Muscle Invasive Bladder Cancer clinical trials that are recruiting, at sites in 3 countries (most in China (3), United States (2), Canada (1)). By phase: Phase 1/2 (2), Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest High-risk Non-Muscle Invasive Bladder Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| NMIBC sample collection to test cancer monitoring biomarkers | — | Austin, Texas | Recruiting | Aug 13, 2026 |
| JL19001 Injection for High-Risk NMIBC (alone or with BCG) | Phase 1 | Chengdu, Sichuan | Recruiting | Mar 19, 2026 |
| HS-10566 treatment in high-risk non-muscle-invasive bladder cancer where surgery isn’t an option | Phase 1/2 | Beijing and 1 other locations | Recruiting | Mar 13, 2026 |
| Evaluating a new treatment for high-risk non-muscle-invasive bladder cancer | Phase 2 | Gilbert, Arizona and 79 other locations | Recruiting | Aug 23, 2024 |
| Evaluating a new treatment for high-risk bladder cancer that expresses HER2 | Phase 1/2 | Guangzhou, Guangdong and 5 other locations | Recruiting | Apr 22, 2024 |
All recruiting trials (5)
-
NMIBC sample collection to test cancer monitoring biomarkers
This study tests a blood, urine, and tumor tissue collection approach in people with high-risk non-muscle invasive bladder cancer to see if a molecular test can detect residual disease and monitor recurrence.
-
JL19001 Injection for High-Risk NMIBC (alone or with BCG)
This early-stage study tests different doses of JL19001 injections to see if they are safe and tolerable in adults with high-risk non-muscle invasive bladder cancer.
-
HS-10566 treatment in high-risk non-muscle-invasive bladder cancer where surgery isn’t an option
This study tests HS-10566 to see if it can help people with high-risk NMIBC who can’t or won’t have radical cystectomy.
-
Evaluating a new treatment for high-risk non-muscle-invasive bladder cancer
This study tests a new treatment for people with high-risk non-muscle-invasive bladder cancer to see if it works better than current options.
-
Evaluating a new treatment for high-risk bladder cancer that expresses HER2
This study is testing a new treatment for high-risk bladder cancer that shows a specific protein called HER2 to see if it is safe and effective for patients.
Related topics
Quick answers
How many High-risk Non-Muscle Invasive Bladder Cancer clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (3 trials), United States (2 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.